CORONAVIRUS/Taiwan-developed Chinese medicine for COVID-19 nearing approval
05/18/2021 05:33 PM
Taipei, May 18 (CNA) A Taiwan-developed Chinese medicine formula used alongside Western medicine to treat COVID-19 patients could be approved for use in Taiwan as early as this week, according to a senior official at the Ministry of Health and Welfare (MOHW).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan reports 23,394 new COVID-19 cases, 45 deathsTaiwan on Tuesday reported 23,394 new cases of COVID-19 and 45 deaths from the disease, according to the Central Epidemic Command Center (CECC).02/07/2023 02:22 PM
- Taiwan begins phasing out Pfizer-BNT as first vaccine shot for minorsTaiwan will stop offering the Pfizer-BioNTech COVID-19 vaccine as a first vaccine shot for children aged 6 months to 4 years and 12-17 years with immediate effect, the Central ...02/06/2023 05:26 PM
- Taiwan reports 16,640 new COVID-19 cases, 63 deathsTaiwan on Monday reported 16,640 new cases of COVID-19 and 63 deaths from the disease, according to the Central Epidemic Command Center (CECC).02/06/2023 02:31 PM
Latest
- Society
Taiwan search and rescue team deployed to Turkey's Adiyaman Province
02/08/2023 11:24 AM - Society
Taiwan headline news
02/08/2023 10:19 AM - Business
U.S. dollar down in Taipei trading
02/08/2023 10:11 AM - Business
Taiwan shares open higher
02/08/2023 09:29 AM - Society
2nd Taiwan search and rescue team Turkey bound following earthquake
02/07/2023 10:57 PM